These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3541046)

  • 21. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism.
    Herholz K; Bauer B; Wienhard K; Kracht L; Mielke R; Lenz MO; Strotmann T; Heiss WD
    J Neural Transm (Vienna); 2000; 107(12):1457-68. PubMed ID: 11458998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood circulation and metabolism of the brain in cerebral diseases in middle and old age].
    Hoyer S
    Z Gerontol; 1982; 15(6):306-13. PubMed ID: 7168232
    [No Abstract]   [Full Text] [Related]  

  • 23. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral glucose metabolism in Parkinson's disease with and without dementia.
    Peppard RF; Martin WR; Carr GD; Grochowski E; Schulzer M; Guttman M; McGeer PL; Phillips AG; Tsui JK; Calne DB
    Arch Neurol; 1992 Dec; 49(12):1262-8. PubMed ID: 1449406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.
    Haxby JV; Grady CL; Duara R; Schlageter N; Berg G; Rapoport SI
    Arch Neurol; 1986 Sep; 43(9):882-5. PubMed ID: 3488728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Energy metabolism in demented brain.
    Sorbi S; Fani C; Piacentini S; Giannini E; Amaducci L
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):591-7. PubMed ID: 3541053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cerebral circulation and metabolism in senile dementia].
    Kaku S
    Nihon Ika Daigaku Zasshi; 1987 Feb; 54(1):100-2. PubMed ID: 3558737
    [No Abstract]   [Full Text] [Related]  

  • 31. [Functional magnetic resonance imaging and dementia].
    Giesel FL; Hempel A; Schönknecht P; Wüstenberg T; Weber MA; Schröder J; Essig M
    Radiologe; 2003 Jul; 43(7):558-61. PubMed ID: 12955219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies.
    Sabayan B; Jansen S; Oleksik AM; van Osch MJ; van Buchem MA; van Vliet P; de Craen AJ; Westendorp RG
    Ageing Res Rev; 2012 Apr; 11(2):271-7. PubMed ID: 22226802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type.
    Kuwabara Y; Ichiya Y; Otsuka M; Masuda K; Ichimiya A; Fujishima M
    Stroke; 1992 Apr; 23(4):594-8. PubMed ID: 1561693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
    Fukuyama H; Ogawa M; Yamauchi H; Yamaguchi S; Kimura J; Yonekura Y; Konishi J
    J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA; Davies P
    J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cerebral aging and amyloid. 1) Senile dementia and amyloid].
    Ishii T
    Nihon Ronen Igakkai Zasshi; 1982 Jul; 19(4):354-8. PubMed ID: 7143788
    [No Abstract]   [Full Text] [Related]  

  • 37. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.
    Mielke R; Herholz K; Grond M; Kessler J; Heiss WD
    Neurobiol Aging; 1992; 13(1):93-8. PubMed ID: 1542386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Senile dementia and presenile dementia.
    Nakamura S
    Tohoku J Exp Med; 1990 Aug; 161 Suppl():49-60. PubMed ID: 1707190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood flow and oxidative metabolism of the brain in patients with dementia (author's transl)].
    Hoyer S; Oesterreich K; Weinhardt F; Krüger G
    J Neurol; 1975 Oct; 210(4):227-37. PubMed ID: 52693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
    Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
    Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.